Proteomics US lab CAP accredited - extends precision Dx lab
Filed with ASX · · 2 pages · English
• Proteomics International USA also completes installation of new mass spectrometry platform that underpins the commercialisation of the suite of new Promarker precision diagnostic blood tests led by PromarkerEso and PromarkerEndo • CAP accreditation for testing of clinical samples is recognised for its rigorous and robust standards, and is widely considered the gold standard for laboratory qualit
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- US patent secured for PromarkerEso diagnostic test for EAC
- PromarkerD predicts risk of DKD in Aboriginal Australians
- Response to ASX Price Query
- US Medicare sets reimbursement price for PromarkerD DKD test
- OxiDx test correlates with superior racehorse performance
Later from Proteomics International Laboratories
- Appointment of CEO and Managing Director
- Canadian patent secured for PromarkerEso test for EAC
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D and Interim Financial Report
- Restructure, Executive Appointment and Board Update
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories